Reports

Drug name	NICE TAs	Comments
Oxaliplatin injection	TA100 - Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer TA33 - The clinical effectiveness and cost effectiveness of irinotecan, oxaliplatin and raltitrexed for colorectal cancer TA212 - Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer
Oxandrolone 2.5mg tablets		Burns use only
Oxybuprocaine Minims
Oxycodone hydrochloride injection
Oxytocin
Ozanimod (Zeposia®)	TA828 - Ozanimod for treating moderately to severely active ulcerative colitis
Ozanimod (Zeposia®)	TA828: Ozanimod for treating moderately to severely active ulcerative colitis
Pabrinex injection
Paclitaxel	TA55 - Guidance on the use of paclitaxel in the treatment of ovarian cancer TA91 - Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer
Paclitaxel injection	TA214 - Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer TA284 - Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer TA389 - Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancer	Negative TA

University Hospitals Birmingham NHS Foundation Trust